Celltrion has submitted a Marketing Authorization Application to the European Medicines Agency for CT-P55, its biosimilar candidate to Novartis' blockbuster drug COSENTYX. The application seeks approval across all European indications including multiple autoimmune conditions, following earlier regulatory filings in Canada and South Korea.

All eyes in the field of mHealth and telehealth technologies are focused on South Korea at the moment.

On December 23, 2015, the Korean Constitutional Court, the final arbiter of constitutional disputes in Korea, issued a pair of companion decisions that clarify the bounds of medical advertisement regulation in Korea.

On June 3, 2017, Korea's version of the "Sunshine Act" will go into effect.

My grandfather passed away when I was 15 years old. For the last three years, he had suffered from dementia. He was once refined like an honorable seonbi, a traditional Korean scholar full of virtue...

As of April 1, 2022, fully vaccinated travelers entering South Korea through designated airports, including Incheon Airport, will be exempt from the government's seven-day quarantine requirement.

These heightened criminal penalties, however, will not be imposed retroactively on violations that took place prior to the effective date of the amendments.

Following the growing public interest and knowledge in health and medical care, the number of medical malpractice lawsuits has drastically increased.